<DOC>
	<DOCNO>NCT01487993</DOCNO>
	<brief_summary>The purpose study determine whether metformin effective reduce BMI insulin resistance obese child adolescent .</brief_summary>
	<brief_title>Metformin Obese Children Adolescents</brief_title>
	<detailed_description>The prevalence obesity child adolescent increase rapidly associate significant medical psychosocial consequence persist adulthood . Obesity may lead metabolic complication , insulin resistance , progress via impaired fast glucose impaired glucose tolerance type 2 diabetes mellitus ( T2DM ) development micro- macro-vascular complication . Metformin , oral anti-diabetic license T2DM adult child 10 year onwards , already use label obese child adolescent insulin resistance , even though specific effect metformin obese child adolescent elucidate , particularly upon long-term use . The rationale study base hypothesis metformin may reduce body mass index ( BMI ) , insulin resistance percentage body-fat obese child adolescent insulin resistance . Further anticipated metformin may delay progression T2DM thereby micro- macro-vascular complication obese child adolescent insulin resistance .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Age ≥ 10 ≤ 16 year study entry Caucasian descent Obesity define BMISDS &gt; 2.3 Insulin resistance define HOMAIR ≥ 3.4 . An obtain informed consent subject parents/caregivers . Presence T2DM ( American Diabetes Association criterion ) Presence endocrine disorder steroid therapy Suspicion polycystic ovarium syndrome ; Height &lt; 1.3 SD target height ; Syndrome disorder without mental retardation ; Use antihyperglycaemic drug ; Pregnancy ( pregnancy test perform , applicable ) ; ( History ) alcohol abuse ; Impaired renal and/or hepatic function ( define GFR &lt; 80 ml/min . GFR=40 x length ( cm ) / serumcreatinin ( μmol/l ALAT &gt; 150 % normal value age ) ; Use ritonavir ; use ACE inhibitor ; Insufficient knowledge Dutch language .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Children</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Metformin</keyword>
	<keyword>Insulin resistance</keyword>
</DOC>